These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2143575)

  • 41. The costs associated with the public health management of a cluster of meningococcal infection in England.
    Letouze D; Yao G; Clarke SC
    Vaccine; 2014 Sep; 32(43):5549-51. PubMed ID: 25173479
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Evaluation of the effectiveness of targeted vaccination with the meningococcal polysaccharide A and C vaccine in one location in the Czech Republic].
    Krízová P; Vlcková J; Bobák M
    Epidemiol Mikrobiol Imunol; 1995 Mar; 44(1):9-14. PubMed ID: 7757351
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Simple method of obtaining erythrocytic diagnostic agents for titration of antimeningococcal antibodies].
    Dalmatov VV; Klishevich VP; Matushchenko AA
    Lab Delo; 1979; (7):426-8. PubMed ID: 89237
    [No Abstract]   [Full Text] [Related]  

  • 44. Immunotherapy of infectious diseases: past, present and future.
    Pennington JE
    Trans Am Clin Climatol Assoc; 1988; 99():126-35. PubMed ID: 3332516
    [No Abstract]   [Full Text] [Related]  

  • 45. Recent developments in the therapy and control of meningococcal infections.
    Feldman HA
    Dis Mon; 1966 Feb; ():1-31. PubMed ID: 5176251
    [No Abstract]   [Full Text] [Related]  

  • 46. [Antimeningococcal plasma in the combined treatment of meningococcal infection in children].
    Sorokina MN; Dadiomova MA; Zinchenko AP; Smirnova AI; Korzhueva NA
    Pediatriia; 1988; (2):80-4. PubMed ID: 3131732
    [No Abstract]   [Full Text] [Related]  

  • 47. [Analysis of industrially produced diagnostic meningococcal agglutinating sera].
    Trushnikova AG
    Lab Delo; 1985; (5):302-4. PubMed ID: 2409341
    [No Abstract]   [Full Text] [Related]  

  • 48. [Comparative evaluation of the methods of monitoring the activity of diagnostic meningococcal group-specific sera].
    Ereshchenko VV; Petrova ZS; Zhukova LF
    Lab Delo; 1982; (9):567-9. PubMed ID: 6183530
    [No Abstract]   [Full Text] [Related]  

  • 49. [Evaluation of the socio-economic effect of using immune anti- meningococcal plasma in pediatric practice].
    Smirnova AI; Kochetygina AA; Nikolaeva LK; Zinchenko AP; Sorokina MN; Romanchenko TG
    Pediatriia; 1990; (3):36-9. PubMed ID: 2143575
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Neisseria meningitidis. The pathophysiological role of lipopolysaccharides in association with meningococcal disease and septic shock].
    Pedersen MØ; Pedersen DS; Pedersen M; Penkowa M
    Ugeskr Laeger; 2008 Feb; 170(6):421-6. PubMed ID: 18252172
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of Meningococcal Disease.
    Nadel S
    J Adolesc Health; 2016 Aug; 59(2 Suppl):S21-8. PubMed ID: 27449146
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Invasive meningococcal disease].
    Sokołowski R; Targowski T
    Pol Merkur Lekarski; 2012 Nov; 33(197):255-60. PubMed ID: 23394035
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evolving meningococcal immunization strategies.
    Sáfadi MA; Bettinger JA; Maturana GM; Enwere G; Borrow R;
    Expert Rev Vaccines; 2015 Apr; 14(4):505-17. PubMed ID: 25494168
    [TBL] [Abstract][Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.